糖化血红蛋白与急性心肌梗死预后关系分析  

Relationship between Glycated Hemoglobin and the Prognosis of Acute Myocardial Infarction

作　　者：徐勇锋[1] 

机构地区：[1]广东省揭阳市中医院,广东揭阳522000

出　　处：《中医临床研究》2015年第15期41-42,共2页Clinical Journal Of Chinese Medicine

摘　　要：目的:初步探讨临床上急性心肌梗死患者糖化血红蛋白含量与其疾病的预后之间的关系,为疾病的临床治疗提供参考。方法:对我院心内科2013年02月—2015年02月收治的106例急性心肌梗死患者临床资料进行回顾性分析,根据患者糖化血红蛋白含量的不同将其分成正常组(糖化血红蛋白<6.0%)和偏高组(糖化血红蛋白≥6.0%),比较两组患者住院期间心源性休克及心力衰竭等症状的发生频率,并且通过NIHSS评分以及治疗后30 d改良情况的Rankin’s评分情况。结果:本研究统计结果表明,偏高组患者的心源性休克及心力衰竭的发生率高于正常组患者,差异极显著(P<0.01);偏高组患者的NIHSS评分及治疗后30 d改良情况的Rankin's评分高于正常组患者,两组差异显著(P<0.05)。结论:本研究结果表明,急性心肌梗死患者的糖化血红蛋白含量升高会导致患者临床疾病的恶化,危害患者生命健康,使得患者疾病的预后不良,因此对于这类患者在临床治疗过程中采用必要措施控制糖化血红蛋白的含量具有十分重要的意义。Objective： To study the relationship between prognosis of acute myocardial infarction and glycated hemoglobin disorders in order to provide reference for clinical treatment of the disease. Methods： 106 cases of acute myocardial infarction treated in the Cardiology of our hospital from February 2013 to February 2015 were retrospectively analyzed and were randomly divided into normal group（glycated hemoglobin〈6.0%） and high group（glycated hemoglobin≥6.0%）,depending on the patient’s glycated hemoglobin contents. We compared the incidence frequency of cardiogenic shock and heart failure of the two groups during hospitalization by NIHSS score and Rankin’s score 30 d improvement. Results： The statistical results showed that the high group had significantly higher incidence of cardiogenic shock and heart failure than the patients of the normal group（P〈0.01）;the high group had higher NIHSS score and Rankin’s scores of 30 d improvements than the normal group of patients, with significant difference（P〈0.05）.Conclusion：Increased glycated hemoglobin levels of patients with acute myocardial infarction can lead to a deterioration of disease, endangering the life and health of patients and then poor prognosis of the disease.Therefore it is necessary to adopt some measures to control the content of glycated hemoglobin for patients with these kinds of diseases.

关 键 词：急性心肌梗死 糖化血红蛋白 预后分析 NIHSS评分 Rankin’s评分 

分 类 号：R542.22[医药卫生—心血管疾病]